$1.31
0.38%
Nasdaq, Oct 02, 04:05 pm EDT. Closed.
ISIN
US3743964062
Symbol
GEVO

Gevo, Inc. Stock price

$1.31
-0.40 23.39% 1M
-0.99 42.92% 6M
-0.69 34.50% YTD
-0.72 35.47% 1Y
+0.21 19.09% 3Y
-4.92 78.97% 5Y
-191.33 99.32% 10Y
-98,638.69 100.00% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
-0.01 0.38%
ISIN
US3743964062
Symbol
GEVO
Sector

Is Gevo, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$323.9m
Enterprise Value
$433.7m
Net debt
$109.8m
Cash
$58.2m
Shares outstanding
247.2m
Valuation
P/E
negative
P/S | estimate
1.8 | 1.6
EV/Sales | estimate
2.4 | 2.2
EV/FCF | ex SBC
negative | negative
P/B
1.2
Financial Health
Equity Ratio
64.9%
Return on Equity
-7.3%
ROCE
-10.9%
ROIC
-
Debt/Equity
0.6
Share-Based Compensation & Dilution
SBC | % of Revenue
$9.7m | 5.5%
SBC as % of FCF
-
SBC Growth 1Y
-4.3%
Share Count Growth 1Y
2.2%
Shareholder Yield
-2.2%
Financials
Revenue | estimate
$177.9m | $199.0m
EBITDA
$-23.4m
EBIT
$-49.6m
Net Income
$-212.9m
Free Cash Flow | ex SBC
$-56.7m | $-66.4m
Growth
Revenue | estimate
121.9% | 24.0%
EBITDA
10.6%
EBIT
-1.9%
Net Income
-264.9%
Free Cash Flow
38.4%
Margin
Gross
47.3%
EBITDA
-13.2%
EBIT
-27.9%
Net
-119.7%
Free Cash Flow | ex SBC
-31.8% | -37.3%
More
EPS
$-0.9
FCF per Share
$-0.2
Short interest
10.1%
Employees
151
Rev per Employee
$1.1m

Gevo, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Gevo, Inc. forecast:

8x Buy
73%
3x Hold
27%

Analyst Opinions

11 Analysts have issued a Gevo, Inc. forecast:

Buy
73%
Hold
27%

Gevo, Inc. Events

Past Events
AUG
6
Q2 2026 Earnings Call
about 2 months ago
MAY
7
Q1 2026 Earnings Call
5 months ago
MAR
5
Q4 2025 Earnings Call
7 months ago
JAN
23
Special Call - Gevo, Inc.
8 months ago
NOV
11
Special Call - Gevo, Inc.
11 months ago
NOV
10
Q3 2025 Earnings Call
11 months ago
OCT
6
Special Call - Gevo, Inc.
12 months ago

Financial data from Gevo, Inc.

Jun '26
+/-
%
178 178
122% 122%
100%
- Direct Costs 94 94
99% 99%
53%
84 84
154% 154%
47%
- Selling and Administrative Expenses 98 98
123% 123%
55%
- Research and Development Expense 4.50 4.50
3% 3%
3%
-23 -23
11% 11%
-13%
- Depreciation and Amortization 26 26
17% 17%
15%
EBIT (Operating Income) EBIT -50 -50
2% 2%
-28%
Net Profit -213 -213
265% 265%
-120%

In millions USD.

Don't miss a Thing! We will send you all news about Gevo, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Gevo, Inc. Stock News

Neutral
GlobeNewsWire
●
3 days ago
ENGLEWOOD, Colo., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced sales of substantially all of the Section 45Z tax credits generated by its ethanol and renewable natural gas (RNG) facilities in 2026, totaling $70 million worth of credits.
Neutral
GlobeNewsWire
●
18 days ago
ENGLEWOOD, Colo and PUNE, India, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Praj Industries and Gevo, Inc. (NASDAQ: GEVO) today announced the signing of a Development & Commercialization Agreement for Bio-Isobutanol (Bio-IBA) technology in India, reinforcing their long-standing association to advance sustainable low-carbon fuel solutions.
Neutral
GlobeNewsWire
●
20 days ago
ENGLEWOOD, Colo., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced continued progress on the debottlenecking initiative at its Gevo North Dakota ("GND") facility in Richardton, North Dakota, including the successful commissioning of a new beer degassing system ahead of schedule which will capture and sequester more CO₂.
More Gevo, Inc. News

Company Profile

Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company's isobutanol technology. The Gevo Development and Agri-Energy segment is currently responsible for the operation of its agri energy facility and the production of ethanol, isobutanol, and related products. The company was founded by Christopher Michael Ryan, Matthew W. Peters, Peter Meinhold, and Frances Hamilton Arnold on June 9, 2005 and is headquartered in Englewood, CO.

Head office United States
CEO Dr. Gruber
Employees 151
Founded 2005
Website gevo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today